245 related articles for article (PubMed ID: 38481662)
1. Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors.
Ma C; Zou M; Xu N; Liu Y; Wang Y
Front Cell Infect Microbiol; 2024; 14():1357090. PubMed ID: 38481662
[TBL] [Abstract][Full Text] [Related]
2. [Research progress on analysis of human papillomavirus by microchip capillary electrophoresis].
Lin X; Wang C; Lin JM
Se Pu; 2020 Oct; 38(10):1179-1188. PubMed ID: 34213114
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
4. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
Hesselink AT; Sahli R; Berkhof J; Snijders PJ; van der Salm ML; Agard D; Bleeker MC; Heideman DA
J Clin Virol; 2016 Mar; 76():36-9. PubMed ID: 26809131
[TBL] [Abstract][Full Text] [Related]
6. Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review.
Biazin H
J Virol Methods; 2022 Mar; 301():114435. PubMed ID: 34919974
[TBL] [Abstract][Full Text] [Related]
7. Strategies for Engineering Affordable Technologies for Point-of-Care Diagnostics of Infectious Diseases.
Zamani M; Furst AL; Klapperich CM
Acc Chem Res; 2021 Oct; 54(20):3772-3779. PubMed ID: 34612619
[TBL] [Abstract][Full Text] [Related]
8. Coupling CRISPR/Cas12a and Recombinase Polymerase Amplification on a Stand-Alone Microfluidics Platform for Fast and Parallel Nucleic Acid Detection.
Zhou H; Xu Z; He L; Wang Z; Zhang T; Hu T; Huang F; Chen D; Li Y; Yang Y; Huang X
Anal Chem; 2023 Feb; 95(6):3379-3389. PubMed ID: 36735954
[TBL] [Abstract][Full Text] [Related]
9. HPV detection methods and genotyping techniques in screening for cervical cancer.
Eide ML; Debaque H
Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
[TBL] [Abstract][Full Text] [Related]
10. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
[TBL] [Abstract][Full Text] [Related]
11. Use of Fast Transfer Analysis Cartridges for Cervical Sampling and Real Time PCR Based High Risk HPV Testing in Cervical Cancer Prevention - a Feasibility Study from South India.
Vijayalakshmi R; Viveka TS; Malliga JS; Murugan K; Kanchana A; Arvind K
Asian Pac J Cancer Prev; 2015; 16(14):5993-9. PubMed ID: 26320486
[TBL] [Abstract][Full Text] [Related]
12. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
[TBL] [Abstract][Full Text] [Related]
13. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
14. A simple and efficient method for potential point-of-care diagnosis of human papillomavirus genotypes: combination of isothermal recombinase polymerase amplification with lateral flow dipstick and reverse dot blot.
Ma B; Fang J; Lin W; Yu X; Sun C; Zhang M
Anal Bioanal Chem; 2019 Nov; 411(28):7451-7460. PubMed ID: 31588523
[TBL] [Abstract][Full Text] [Related]
15. Advances in early diagnosis of cervical cancer based on biosensors.
Ghaleh HEG; Shahriary A; Izadi M; Farzanehpour M
Biotechnol Bioeng; 2022 Sep; 119(9):2305-2312. PubMed ID: 35665484
[TBL] [Abstract][Full Text] [Related]
16. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
17. Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
Nakowong P; Chatchawal P; Chaibun T; Boonapatcharoen N; Promptmas C; Buajeeb W; Lee SY; Jearanaikoon P; Lertanantawong B
Talanta; 2024 Mar; 269():125495. PubMed ID: 38043336
[TBL] [Abstract][Full Text] [Related]
18. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus.
Barcellos RB; Almeida SE; Sperhacke RD; Verza M; Rosso F; Medeiros RM; Perizzolo PF; Cortez-Herrera E; Rossetti ML
J Virol Methods; 2011 Oct; 177(1):38-43. PubMed ID: 21807028
[TBL] [Abstract][Full Text] [Related]
20. High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.
Geraets DT; Heideman DA; de Koning MN; Snijders PJ; van Alewijk DC; Meijer CJ; van Doorn LJ; Quint WG
J Clin Virol; 2009 Nov; 46 Suppl 3():S21-6. PubMed ID: 20129070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
